Does Velpatasvir And Sofosbuvir Interact with Rosuvastatin Calcium?
CDI records a major classification for Velpatasvir And Sofosbuvir and Rosuvastatin Calcium. The stored summary is: Increases rosuvastatin exposure. Limit rosuvastatin dose to 10 mg once daily. The mechanism involves increased rosuvastatin exposure. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Major
- Velpatasvir And Sofosbuvir Class
- Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Increased rosuvastatin exposure
What To Tell Your Doctor or Pharmacist
If you are taking Velpatasvir And Sofosbuvir and your doctor is considering prescribing Rosuvastatin Calcium (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider